Skip to main content

DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Takeover By Sun Pharmaceutical Industries Limited

  • If you purchased shares of DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) prior to November 8, 2012, and currently hold any of those NASDAQ:DUSA shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Nov. 8, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) shares was announced concerning whether the offer by Sun Pharmaceutical Industries Limited to acquire DUSA Pharmaceuticals, Inc. for $8.00 per NASDAQ:DUSA share and the takeover process are unfair to investors in NASDAQ:DUSA shares. The investigation by a law f...



You must register (for free) or login to view the entire investigation.